Urinary incontinence. Methods of treatment
- Authors: Ilyina IY.1, Dobrokhotova Y.E1, Narimanova MR1, Chikisheva AA1, Malikova VO1, Goncharov IY.1
-
Affiliations:
- N.I.Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation
- Issue: Vol 20, No 1 (2018)
- Pages: 92-95
- Section: Articles
- URL: https://ogarev-online.ru/2079-5831/article/view/30070
- DOI: https://doi.org/10.26442/2079-5696_20.1.92-95
- ID: 30070
Cite item
Full Text
Abstract
Urinary incontinence is a serious social and medical problem in Russia and throughout the world. However, even a small percentage of women who purposefully go to the doctor about having incontinence symptoms, only 2% of patients receiving the qualified urological aid. Medical therapy is used as the primary method for all patients with an overactive bladder. As the drugs of choice, the use of M-cholinolytics affecting muscarinic receptors of the bladder is recommended. The article presents data indicating the possibility of using trospium chloride in patients of different age categories. Objective - to determine the effectiveness of the use of M-cholinolytic drug (trospium chloride) in women of different age categories. Material and methods. The study included 68 patients with symptoms of a hyperactive bladder, which, depending on their age, were divided into 2 groups. All patients received trospium chloride (Spasmex®) for 6 months. Results. After 3 and 6 months of the use of trospium chloride in patients of both groups, the complaints decreased significantly. Attention is drawn to the fact that the decrease in the number of complaints during the treatment significantly decreased more in the first three months. In women of the reproductive period, the results are more significant than in postmenopausal patients, which can be explained by the presence of hypoestrogenic condition in patients of the 2nd group, which can make the pathology worse and require the appointment of etiopathogenetic treatment. Conclusion. Trospium chloride can be recommended to patients reproductive and postmenopausal periods for relief of symptoms of overactive bladder with the contraindications. In postmenopausal women, in addition to taking trospium chloride, the need to prescribe menopausal hormone therapy (systemic, local) should be considered to compensate for the deficiency of estrogen. In the presence of prolapse of the genitals and stress component of urinary incontinence, it is necessary to resolve the issue of the need for timely surgical treatment aimed at coping with stress urinary incontinence and correction of prolapse of the genitals.
Full Text
##article.viewOnOriginalSite##About the authors
I Yu Ilyina
N.I.Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation
Email: iliyina@mail.ru
д-р мед. наук, проф. каф. акушерства и гинекологии лечебного фак-та 117997, Russian Federation, Moscow, ul. Ostrovitianova, d. 1
Yu E Dobrokhotova
N.I.Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation
Email: iliyina@mail.ru
д-р мед. наук, проф., зав. каф. акушерства и гинекологии лечебного фак-та
117997, Russian Federation, Moscow, ul. Ostrovitianova, d. 1M R Narimanova
N.I.Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation
Email: iliyina@mail.ru
канд. мед. наук, ассистент каф. акушерства и гинекологии лечебного фак-та
117997, Russian Federation, Moscow, ul. Ostrovitianova, d. 1A A Chikisheva
N.I.Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation
Email: iliyina@mail.ru
ассистент каф. акушерства и гинекологии лечебного фак-та
117997, Russian Federation, Moscow, ul. Ostrovitianova, d. 1V O Malikova
N.I.Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation
Email: iliyina@mail.ru
ассистент каф. акушерства и гинекологии лечебного фак-та
117997, Russian Federation, Moscow, ul. Ostrovitianova, d. 1I Yu Goncharov
N.I.Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation
Author for correspondence.
Email: iliyina@mail.ru
ассистент каф. акушерства и гинекологии лечебного фак-та
117997, Russian Federation, Moscow, ul. Ostrovitianova, d. 1References
- Abrams P, Cardozo L, Fall М et al. The standartization of terminology in lower urinary tract function. Neurol Urodyn 2002; 21: 167-78.
- Гаджиева З.К. Нарушения мочеиспускания. Под ред. Ю.Г.Аляева. М.: ГЭОТАР-Медиа, 2010
- Недержание мочи у женщин. Клинические рекомендации. М., 2016.
- Алексеева Г.С., Трифонова Н.Ю., Вирясов А.В., Лившиц С.А. Обоснование организации возрастно-ориентированного оказания помощи женщинам пожилого возраста с недержанием мочи. Социальные аспекты здоровья населения. 2015; 2.
- Ильина И.Ю., Доброхотова Ю.Э., Маликова В.О., Чикишева А.А. Особенности мочеиспускания у гинекологических больных. Гинекология. 2013; 15 (5): 48-50.
- Botlero R, Urquhart D.M, Davis S.R, Bell R.J. Prevalence and incidence of urinary incontinence in women: review of the literature and investigation of methodological issues. Int J Urol 2008; 15: 230-4.
- Даренков С.П., Кривобородов Г.Г., Ефремов Н.С. и др. Регулируемый субуретральный слинг в лечении анатомического типа стрессового недержания мочи у женщин. Вест. РГМУ. 2012; 1: 66-70
- Serati M, Salvatore S, Uccella S et al. Surgical treatment for female stress urinary incontinence: what is the gold-standard procedure? Urogynecol J 2009; 20: 619-21.
- Angioli R, Plotti F, Muzii L et al. Tension-free vaginal tape versus transobturator suburethral tape: five-year follow-up results of a prospective, randomised trial. Eur Urol 2010; 58: 671-7.
- Al-Badr A, Ross S, Soroka D et al. Voiding patterns and urodynamics after a tensionfree vaginal tape procedure. J Obstet Gynecol Can 2003; 25: 725-30.
- Мазо Е.Б., Школьников М.Е., Кривобородов Г.Г. Гиперактивный мочевой пузырь у больных пожилого возраста. Consilium Medicum. 2006; 8 (12): 97-101.
- Борисов В.В. Гиперактивный мочевой пузырь: эффективное лечение. Consilium Medicum. 2014; 16 (7): 22-8.
- Мазо Е.Б., Кривобородов Г.Г. Гиперактивный мочевой пузырь. М.: Вече, 2003.
- Ромих В.В. Гиперактивный мочевой пузырь: на перекрестке урологии и гинекологии. Гинекология. 2007; 9 (4): 34-7
- Камоева С.В. Патогенетические аспекты прогнозирования, диагностики и лечения пролапса тазовых органов. Автореф. дис.. д-ра мед. наук. М., 2014.
- Радзинский В.Е. Перинеология. М.: Мед. информ. агентство, 2006.
- Прилепская В.Н., Назаренко Е.Г. Эстриол в терапии различных гинекологических заболеваний. Мед. совет. 2017; 2: 12-1
Supplementary files
